Celltrion has partnered with Japan’s largest bio cluster, the Kobe Biomedical Innovation Cluster (KBIC), to support the global expansion of promising biotech startups. The collaboration was announced at an offline briefing held on the 8th at the Tokyo LINK‑J (Life Science Innovation Network Japan) headquarters.
The initiative, named the “2026 KBIC‑Celltrion Global Scale‑up Program,” marks the first time a Korean company co‑plans and operates a program with a Japanese bio cluster, representing a historic Korea‑Japan public‑private partnership aimed at accelerating biotech innovation and market entry.
Daily NewsSep 20, 2026•1 min read
Celltrion & Kobe Cluster Launch 2026 Global Scale‑up Program
Celltrion announced a partnership with Japan’s Kobe Biomedical Innovation Cluster, launching the 2026 KBIC‑Celltrion Global Scale‑up Program to help promising biotech startups expand globally.
Compiled by the PharmaCountry team · Source: KPA News
Ratings
(0)
(0)
(0)
(0)
(0)
More articles
View all insightsResearch & Reports
Global Finished Dosage Manufacturing Landscape 2026
Oct 5, 2026
Regulatory UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
Sep 28, 2026
AnalysisPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
Sep 28, 2026
Leave your rating